Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
PharmAbcine Receives IND Approval from the Korean MFDS for Phase I Clinical Trial of Its Novel TIE2 Agonistic Antibody in nAMD
2023-05-23 20:00
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum
2023-05-23 20:00
BrightInsight Named 2023 Global Company of the Year by Frost & Sullivan for Enabling Better Patient Outcomes with Digital Solutions
2023-05-23 20:00
Minghui Pharmaceutical Inc. Announces First-in-Human Dose of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody in Phase 1a Healthy Volunteer Study
2023-05-23 19:00
Strong first quarter 2023: Sales of Exyte increases by a third year-on year to 2.0 billion euros
2023-05-23 19:00
Introducing Ceretone's Core One: The Revolutionary OTC Hearing Aid Launching on Indiegogo in May
2023-05-23 18:01
Antengene Announces Claudin 18.2 Antibody-Drug Conjugate ATG-022 Granted Orphan Drug Designations by the U.S. FDA for the Treatment of Gastric and Pancreatic Cancers
2023-05-23 17:25
CPIC: Focusing on the Health Industry and Building a New Ecosystem of "Insurance + Health"
2023-05-23 16:12
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History
2023-05-23 14:00
OMRON Healthcare Celebrates 50 Years of Blood Pressure Monitor History
2023-05-23 14:00
Chula Medicine Found Thai Herbal Tea Comparable to Modern Medicines in Stimulating Breast Milk Production
2023-05-23 13:39
Nona Biosciences Enters into Antibody Discovery Agreement with OPKO Health's ModeX Therapeutics
2023-05-23 13:00
Xinhua Silk Road: E. China's Shandong holds 5th sports games for seniors in coastal Rizhao City
2023-05-23 12:16
Bowtie upgrades its VHIS for three consecutive years
2023-05-23 11:54
Acepodia Announces First Patient Dosed in Phase 1 Clinical Trial of ACE1831, an Anti-CD20 Armed Allogeneic Gamma Delta T-cell Therapy in Development to Treat Patients with Non-Hodgkin's Lymphoma
2023-05-23 00:00
Angel Yeast Unveils New Products and Solutions at Bakery China 2023
2023-05-22 22:30
HanX Biopharmaceuticals announces HX009 IND approval from FDA
2023-05-22 22:00
CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech
2023-05-22 21:23
EBR Systems' Pivotal SOLVE-CRT Trial Meets Endpoints: Excellent Interim Analysis Results Lead to Early Trial Halt for Success
2023-05-22 21:00
Sunrise Group among the world's top ten chemical distributors
2023-05-22 20:26
1
158
159
160
161
162
1508